Intervention Review

Postoperative adjuvant chemotherapy in rectal cancer operated for cure.

  1. Sune Høirup Petersen1,*,
  2. Henrik Harling2,
  3. Lene Tschemerinsky Kirkeby3,
  4. Peer Wille-Jørgensen4,
  5. Simone Mocellin5

Editorial Group: Cochrane Colorectal Cancer Group

Published Online: 14 MAR 2012

Assessed as up-to-date: 31 JAN 2012

DOI: 10.1002/14651858.CD004078.pub2


How to Cite

Petersen SH, Harling H, Kirkeby LT, Wille-Jørgensen P, Mocellin S. Postoperative adjuvant chemotherapy in rectal cancer operated for cure.. Cochrane Database of Systematic Reviews 2012, Issue 3. Art. No.: CD004078. DOI: 10.1002/14651858.CD004078.pub2.

Author Information

  1. 1

    Bispebjerg Hospital, building 11B, Colorectal Cancer Group, Copenhagen NV, Denmark

  2. 2

    Bispebjerg Hospital, Surgical dept. K, Copenhagen NV, Denmark

  3. 3

    Roskilde Hospital, Surg. Department A, Roskilde, Denmark

  4. 4

    Bispebjerg Hospital, Department of Surgical Gastroenterology K, Copenhagen NV, Denmark

  5. 5

    University of Padova, Meta-Analysis Unit, Department of Oncological & Surgical Sciences, Padova, Veneto, Italy

*Sune Høirup Petersen, Colorectal Cancer Group, Bispebjerg Hospital, building 11B, 23 Bispebjerg Bakke, Copenhagen NV, DK 2400, Denmark. SPET0035@bbh.regionh.dk.

Publication History

  1. Publication Status: New, comment added to review
  2. Published Online: 14 MAR 2012

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Emily K. Bergsland, Is More Not Better?, Hematology/Oncology Clinics of North America, 2015, 29, 1, 85

    CrossRef

  2. 2
    M. Koczorek, 20. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) in Düsseldorf 2014, Der Onkologe, 2014, 20, 10, 1018

    CrossRef

  3. 3
    Anne J Breugom, Cornelis J H van de Velde, Adjuvant chemotherapy for patients with rectal cancer?, The Lancet Oncology, 2014, 15, 11, 1185

    CrossRef

  4. 4
    Jean-François Bosset, Gilles Calais, Laurent Mineur, Philippe Maingon, Suzana Stojanovic-Rundic, René-Jean Bensadoun, Etienne Bardet, Alexander Beny, Jean-Claude Ollier, Michel Bolla, Dominique Marchal, Jean-Luc Van Laethem, Vincent Klein, Jordi Giralt, Pierre Clavère, Christoph Glanzmann, Patrice Cellier, Laurence Collette, Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study, The Lancet Oncology, 2014, 15, 2, 184

    CrossRef

  5. 5
    Yong Sang Hong, Byung-Ho Nam, Kyu-pyo Kim, Jeong Eun Kim, Seong Joon Park, Young Suk Park, Joon Oh Park, Sun Young Kim, Tae-You Kim, Jee Hyun Kim, Joong Bae Ahn, Seok-Byung Lim, Chang Sik Yu, Jin Cheon Kim, Seong Hyeon Yun, Jong Hoon Kim, Jin-hong Park, Hee Chul Park, Kyung Hae Jung, Tae Won Kim, Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial, The Lancet Oncology, 2014, 15, 11, 1245

    CrossRef

  6. 6
    Marco E. Allaix, Alessandro Fichera, Modern Rectal Cancer Multidisciplinary Treatment: The Role of Radiation and Surgery, Annals of Surgical Oncology, 2013, 20, 9, 2921

    CrossRef